Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Omérov, Majda
Wistedt, Börje
and
Elgen, Kjell
1995.
Treatment of acutely disturbed psychotic patients: assessment of a new treatment strategy.
Nordic Journal of Psychiatry,
Vol. 49,
Issue. sup35,
p.
63.
Emerson, Eric
1996.
Behavioural and pharmacological methods for promoting positive behaviour.
Current Opinion in Psychiatry,
Vol. 9,
Issue. 5,
p.
332.
Carvajal, Alfonso
and
Martín Arias, Luis H.
1997.
Vol. 20,
Issue. ,
p.
36.
Grinshpoon, A
Moskowitz, M
Valevski, A
Kreizman, A
Palei, L
Mar, M
and
Weizman, A
1998.
Zuclopenthixol, D1/D2 antagonist, for treatment of chronic aggressive schizophrenia and psychotic oligophrenic patients.
European Psychiatry,
Vol. 13,
Issue. 5,
p.
273.
Santosh, Paramala Janardhanan
and
Baird, Gillian
1999.
Psychopharmacotherapy in children and adults with intellectual disability.
The Lancet,
Vol. 354,
Issue. 9174,
p.
233.
Antochi, R
Stavrakaki, C
and
Emery, P C
2003.
Psychopharmacological treatments in persons with dual diagnosis of psychiatric disorders and developmental disabilities.
Postgraduate Medical Journal,
Vol. 79,
Issue. 929,
p.
139.
Gibson, Roger Carl
Fenton, Mark
da Silva Freire Coutinho, Evandro
Campbell, Colin
and
Gibson, Roger Carl
2004.
Cochrane Database of Systematic Reviews.
Antochi, Ruxandra M
and
Stavrakaki, Chrissoula
2004.
Determining Pharmacotherapy Options for Behavioral Disturbances in Patients With Developmental Disabilities.
Psychiatric Annals,
Vol. 34,
Issue. 3,
p.
205.
Kumar, Ajit
and
Strech, Daniel
2005.
Zuclopenthixol dihydrochloride for schizophrenia.
Cochrane Database of Systematic Reviews,
Malfa, Giampaolo La
Lassi, Stefano
Bertelli, Marco
and
Castellani, Alessandro
2006.
Reviewing the use of antipsychotic drugs in people with intellectual disability.
Human Psychopharmacology: Clinical and Experimental,
Vol. 21,
Issue. 2,
p.
73.
Haessler, Frank
Glaser, Thomas
Beneke, Manfred
Pap, Akos F.
Bodenschatz, Ralf
and
Reis, Olaf
2007.
Zuclopenthixol in adults with intellectual disabilities and aggressive behaviours.
British Journal of Psychiatry,
Vol. 190,
Issue. 5,
p.
447.
Deb, S.
Sohanpal, S. K.
Soni, R.
Len tre, L.
and
Unwin, G.
2007.
The effectiveness of antipsychotic medication in the management of behaviour problems in adults with intellectual disabilities.
Journal of Intellectual Disability Research,
Vol. 51,
Issue. 10,
p.
766.
Häßler, Frank
and
Reis, Olaf
2010.
Pharmacotherapy of disruptive behavior in mentally retarded subjects: A review of the current literature.
Developmental Disabilities Research Reviews,
Vol. 16,
Issue. 3,
p.
265.
Häßler, F.
2011.
Psychiatrie, Psychosomatik, Psychotherapie.
p.
2305.
Jayakody, Kaushadh
Gibson, Roger Carl
Kumar, Ajit
and
Gunadasa, Shalmini
2012.
Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses.
Cochrane Database of Systematic Reviews,
Dold, Markus
Samara, Myrto T
Li, Chunbo
Tardy, Magdolna
and
Leucht, Stefan
2015.
Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
Cochrane Database of Systematic Reviews,
Vol. 2015,
Issue. 1,
Deb, Shoumitro
2016.
Handbook of Evidence-Based Practices in Intellectual and Developmental Disabilities.
p.
347.
Bryan, Edward J
Purcell, Marie Ann
and
Kumar, Ajit
2017.
Zuclopenthixol dihydrochloride for schizophrenia.
Cochrane Database of Systematic Reviews,
Vol. 2017,
Issue. 11,
2021.
The Maudsley Prescribing Guidelines in Psychiatry.
p.
777.
Deb, Shoumitro Shoumi
Bertelli, Marco O.
and
Rossi, Michele
2022.
Textbook of Psychiatry for Intellectual Disability and Autism Spectrum Disorder.
p.
247.
eLetters
No eLetters have been published for this article.